secwatch.observer — SEC 8-K summary
======================================

Issuer:     IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
CIK:        0001425205
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001104659-24-121612
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 1.01, 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Iovance Biotherapeutics relocates HQ within same building, cutting monthly rent by ~64%
--------------------------------------------------------------------------------

- Entered 24-month sublease for 16,731 sq ft at 825 Industrial Road, San Carlos, starting Nov 15, 2024.
- Monthly base rent: $99,550 first 12 months, $102,536 second 12 months, down from $279,541 under prior lease.
- Terminated prior lease for 49,918 sq ft (Suite 400) effective by Dec 31, 2024, with a lease modification payment.
- Relocation reflects cost reduction efforts with significantly reduced square footage and operating costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425205/000110465924121612/0001104659-24-121612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425205/000110465924121612/tm2429156d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-121612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer